Paid Clinical Trials in Tacoma, WA

As of September 2026, 145 paid clinical trials are recruiting in Tacoma, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

143 clinical trials

Get a weekly email when new trials open in Tacoma, WA.

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

for Posttraumatic Headache

Sites in Tacoma +3 more locations

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All·Age: 18 - 50

Code: NCT05049057·Phase 2·Recruiting·Listed Sep 2021

Apply to this trial

Lay-Delivered Behavioral Activation in Senior Centers

for Depression

Sites in Tacoma, Enumclaw +16 more locations

Sponsor: University of Washington

Sex: All·Age: 60+

Code: NCT04621877·Recruiting·Listed Nov 2020

Apply to this trial

Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial

for Low Back Pain

1 location in Tacoma

Sponsor: Madigan Army Medical Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT04704297·Phase 4·Recruiting·Listed Jan 2021

Apply to this trial

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for Crohn's Disease

Sites in Tacoma, Bellevue +39 more locations

Sponsor: AbbVie

Sex: All·Age: 18 - 75

Code: NCT07697456·Phase 2·Recruiting·Listed Jul 2026

Apply to this trial

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

for High-risk Muscle Invasive Urothelial Carcinoma

Drug: Rilvegostomig

Sites in Tacoma, Seattle +16 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07720284·Phase 3·Recruiting·Listed Jul 2026

Apply to this trial

EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine

for Migraine Disorders

1 location in Tacoma

Sponsor: Cortex Neurovascular

Sex: All·Age: 18 - 64

Code: NCT07652034·Recruiting·Listed Jun 2026

Apply to this trial

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

for Relapsed/Refractory Multiple Myeloma (RRMM)

Drug: Linvoseltamab

Sites in Tacoma +3 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07609940·Phase 4·Recruiting·Listed May 2026

Apply to this trial

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

for Metastatic Castration-resistant Prostate Cancer

Sites in Tacoma +24 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT07611110·Phase 3·Recruiting·Listed May 2026

Apply to this trial

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for Rhabdomyosarcoma

Sites in Tacoma, Seattle +83 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery

for Ureter Injury

Sites in Tacoma +8 more locations

Sponsor: Intuitive Surgical

Sex: All·Age: 16 - 75

Code: NCT07346066·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for Non-small Cell Lung Cancer (NSCLC)

Sites in Tacoma +47 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07291037·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

for Alcohol Use Disorder

Sites in Tacoma +18 more locations

Sponsor: VA Office of Research and Development

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT07218354·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for Gastrointestinal Neoplasms

Sites in Tacoma, Seattle +46 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT07218926·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for Non-squamous Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Tacoma, Seattle +60 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06627647·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for Non-Small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Tacoma, Wenatchee +47 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06357533·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for Untreated Follicular Lymphoma

Drug: Rituximab

Sites in Tacoma +55 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06549595·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Tacoma, Olympia +63 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

for Diffuse Large B-Cell Lymphoma

Drug: Rituximab

Sites in Tacoma +1 more location

Sponsor: AstraZeneca

Sex: All·Age: 65 - 99

Code: NCT05952024·Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for Advanced Breast Cancer

Drug: Camizestrant

Sites in Tacoma +39 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06380751·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

Sites in Tacoma, Puyallup +308 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Tacoma +28 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06350097·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for Breast Cancer

Drug: Durvalumab

Sites in Tacoma +35 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06103864·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial